
How J&J and AstraZeneca differ from the mRNA vaccines from Pfizer and Moderna
Johnson & Johnson's single-dose COVID-19 vaccine has hit a stumbling block in the United States as regulators begin investigating reports of blood clots, weeks before the first shipment of the jabs are expected to arrive in Canada.